About 30 results found for searched term "Ginsenoside-Ro" (0.096 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4089 | Ginsenoside-Ro | Calcium Channel |
| Polysciasaponin P3; Chikusetsusaponin 5; Chikusetsusaponin V; Ginsenoside-Ro | ||
| Ginsenoside Ro (Polysciasaponin P3; Chikusetsusaponin 5; Chikusetsusaponin V) has the antiplatelet effect of Ca2+ antagonist with IC50 of 155 μM. Ginsenoside Ro decreased TXA2 production and Ginsenoside Ro also slightly decreased COX-1 and TXAS activity. | ||
| M3883 | 20(S)-Protopanaxatriol | GCR |
| g-PPT | ||
| 20(S)-Protopanaxatriol (PPT), one of the aglycones of ginsenosides, has been shown to exert cardioprotective effects against myocardial ischemic injury. | ||
| M3940 | Ginsenoside Rg1 | Amyloid |
| G-Rg1; Panaxoside Rg1 | ||
| Ginsenoside Rg1 is part of a class of triterpene saponins and steroid glycosides. Ginsenoside Rg1 ameliorates the impaired cognitive function, displays promising effects by reducing cerebral Aβ levels. It is found exclusively in the plant genus Panax, or ginseng. | ||
| M4066 | Ginsenoside-Rb3 | NF-κB |
| Gypenoside IV | ||
| Ginsenoside Rb3 is derived from Panax Notoginseng. Ginsenoside Rb3 inhibited NF-κB transcriptional activity induced by TNFα in 293T cell lines with IC50 of 8.2 μM. Ginsenoside Rb3 also inhibited the induction of COX-2 and iNOS mRNA. | ||
| M4069 | (S)Ginsenoside-Rh1 | PPAR |
| Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1; Ginsenoside-Rh1 | ||
| Ginsenoside Rh1 (Prosapogenin A2) inhibited the expression of PPAR-γ, TNF-α, IL-6 and IL-1β. | ||
| M4070 | (S)Ginsenoside-Rh2 | Caspase |
| 20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2 | ||
| (S)Ginsenoside-Rh2 is isolated from the root of Ginseng, induces the activation of caspase-8 and caspase-9. | ||
| M4076 | Ginsenoside-Rf | Calcium Channel |
| Panaxoside Rf | ||
| Ginsenoside Rf is a trace component of ginseng root. Ginsenoside Rf inhibits N-type Ca2+ channels. | ||
| M4077 | Pseudoginsenoside-RT5 | Others |
| Pseudoginsenoside RT5 was isolated from Panax quinquefolium. | ||
| M4078 | (R)Ginsenoside-Rh1 | Others |
| (R)Ginsenoside-Rh1 is one of the important protopanaxatriol ginsenosides and has been reported to be the main hydrolysis product reaching the systemic circulation after oral ingestion of ginseng. | ||
| M4079 | (R)Ginsenoside-Rh2 | MMP |
| 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as an anti-proliferative agent in cells. It has anticancer effects by blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis and has anti-inflammatory and antioxidant activities. 20(R)-Ginsenoside Rh2 inhibited the replication and proliferation of mouse and human γ herpevirus 68 (MHV-68) with an IC50 of 2.77 μM against mouse MHV-68. | ||
| M4081 | (R)Ginsenoside-Rg3 | Others |
| (20R)-Propanaxadiol; R-ginsenoside Rg3 | ||
| (20R) -Ginsenoside Rg3 ((20R)-Propanaxadiol), an active compound from ginseng root, has inhibitory effects on vascular endothelial cell proliferation (IC50= 10 nM) and antitumor activity. | ||
| M4084 | Ginsenoside-F2 | Apoptosis |
| Ginsenoside F2, a metabolite of Ginsenoside Rb1, induces apoptosis and protective autophagy in breast cancer stem cells. | ||
| M4085 | Ginsenoside-F3 | IL Receptor/Related |
| Ginsenoside F3, a saponin extracted from Panax ginseng leaves, exerts immune-enhancing activity by regulating the production and expression of il-2 (IFN-γ) and IL-4 and IL-10. | ||
| M4086 | Ginsenoside-F4 | Apoptosis |
| Ginsenoside F4 (GF4), Ginsenoside, isolated from Panax notoginseng or red ginseng. Ginsenoside F4 (GF4) can inhibit human lymphocytic tumor JK cells by inducing apoptosis. Ginsenoside F4 (GF4) inhibited the expression of matrix metalloproteinase 13 (MMP 13) in IL-1β -treated chondrocytes, blocked cartilage damage in rabbit cartilage tissue culture, and prevented cartilage collagen matrix decomposition in pathological tissues. | ||
| M4087 | Ginsenoside-F5 | Apoptosis |
| Ginsenoside F5, which was obtained from Panax ginseng, significantly inhibited the growth of HL-60 cells through apoptosis pathway. | ||
| M4092 | Ginsenoside-Rk1 | NF-κB |
| Ginsenoside Rk1 is a high-temperature processed extract of ginseng. Ginsenoside Rk1 has anti-inflammatory effects and inhibits Jak2/Stat3 signaling pathway and NF-κB activation. | ||
| M4095 | Notoginsenoside-Fe | Others |
| Notoginseng triterpenes; Ginsenoside Mb | ||
| Notoginsenoside Fe(Notoginsenoside Fe) is a natural compound isolated from the varieties of Marsupium. | ||
| M4101 | Notoginsenoside-R1 | Amyloid |
| Sanchinoside R1; Sanqi glucoside R1 | ||
| Notoginsenoside R1 (Sanchinoside R1) is a saponin isolated from P. notoginseng. Notoginsenoside R1 has antioxidant, anti-inflammatory, anti-angiogenic and anti-apoptotic activities. Notoginsenoside R1 provides cardiac protection against ischemia/reperfusion (I/R) injury. Notoginsenoside R1 may also provide neuroprotection. | ||
| M4103 | 20(S)-Notoginsenoside-R2 | Others |
| 20(R)-Notoginsenoside R2 is a saponin isolated from Panax Notoginseng. | ||
| M4104 | 20(S)-NotoginsenosideR2 | Apoptosis |
| 20(S)-Notoginsenoside R2; Ginsenoside Ng-R2 | ||
| Notoginsenoside R2(Notoginsenoside R2) is a newly isolated panax Notoginsenoside R2, which showed protective effects against oxidative stress and cell apoptosis induced by 6-OHDA. | ||
| M18476 | Notoginsenoside Fa | Others |
| Notoginsenoside Fa is a protopanaxadiol (ppd)-type saponin isolated from P. notoginseng, could possibly activate and recover the function of degenerated brain. | ||
| M18477 | Notoginsenoside Fc | Autophagy |
| Notoginsenoside Fc is a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy. | ||
| M18678 | Ginsenoside Rk2 | Immunology/Inflammation |
| Ginsenoside Rk2 is a dammarane glycoside isolated from the processed ginseng (SG; Sun Ginseng), with anti-tumor, and anti-platelet aggregation activities. | ||
| M38660 | Ginsenoside Rg4 | Antibiotic |
| Ginsenoside Rg4 is a major protopanaxatriol type ginsenoside isolated from the leaves of Panax ginseng C. A. Meyer. It exhibits various biological activities including anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant activity. | ||
| M39911 | 5,6-Didehydroginsenoside Rd | Others |
| 5,6-Didehydroginsenoside Rd is a dammarane-type saponin isolated from the dried roots of Panax notoginseng. | ||
| M39962 | Notoginsenoside FP2 | Others |
| Notoginsenoside FP2, a dammarane-Type Bisdesmoside isolated from the Fruit Pedicels of Panax notoginseng, has potential to treat cardiovascular disease. | ||
| M39967 | Vinaginsenoside R4 | Others |
| Vinaginsenoside R4, isolated from the leaves of hydroponic Panax ginseng. It has an inhibitory effect on melanin biosynthesis without any cytotoxic effects on the melan-a cells, and enhances the depigmentation on the zebrafish. | ||
| M39970 | Vinaginsenoside R3 | Others |
| Vinaginsenoside R3 is a saponin composition of roots of Panax ginseng. Ginsengs have been not only used as therapeutic agents with tonic, anti-fatigue, and anti-gastric ulcer effect but also marketed as dietary supplements and raw materials of health food. | ||
| M39971 | Vinaginsenoside R8 | Others |
| Vinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM). | ||
| M39972 | Notoginsenoside T5 | Others |
| Notoginsenoside T5 is a dammarane 61 glycoside. Notoginsenoside T5 is isolated from the acidic deglycosylation of saponins from the roots of P. 62 notoginseng. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
